Aevi Genomic Medicine (LSE:MEDU) Other Financing : £0.00 Mil (TTM As of Sep. 2019)

View and export this data going back to . Start your Free Trial

What is Aevi Genomic Medicine Other Financing?

Aevi Genomic Medicine's Other Financing for the three months ended in Sep. 2019 was £0.00 Mil.

Aevi Genomic Medicine's Other Financing for the trailing twelve months (TTM) ended in Sep. 2019 was £0.00 Mil.

Aevi Genomic Medicine Other Financing Historical Data

The historical data trend for Aevi Genomic Medicine's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aevi Genomic Medicine Other Financing Chart

Aevi Genomic Medicine Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Other Financing

Get a 7-Day Free Trial

0.80

0.95

0.15

0.01

0.03

Aevi Genomic Medicine Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Other Financing	Get a 7-Day Free Trial															-	-	-	-	-

Aevi Genomic Medicine Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was £0.00 Mil.

Aevi Genomic Medicine Other Financing Related Terms

Thank you for viewing the detailed overview of Aevi Genomic Medicine's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Aevi Genomic Medicine (LSE:MEDU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aevi Genomic Medicine Inc (LSE:MEDU) » Definitions » Other Financing

Comparable Companies

Traded in Other Exchanges

N/A

Address

435 Devon Park Drive, Suite 715, Wayne, PA, USA, 19087

Website

http://www.aevigenomics.com

Medgenics is a clinical-stage biopharmaceutical company involved mainly in genomic medicine. Genomic medicine involves the usage of individual's genomic information to decide upon clinical care. This medical discipline is used in the fields of oncology, pharmacology, rare and undiagnosed diseases, and infectious diseases. Medgenics' partner is the Center for Applied Genomics at the Children's Hospital of Philadelphia, with which it works to develop drugs by implementing genomics medicine.

Aevi Genomic Medicine (LSE:MEDU) Headlines

No Headlines